Chicago, IL -- (SBWIRE) -- 08/17/2017 -- Insomnia is a sleep disorder wherein the person finds difficulty in sleeping or to remain asleep. Person suffers from improper sleep patterns and feels irritated, experiences low stamina, depression and sleepiness in daytime. Insomnia is caused due to various biological, behavioral and psychological reasons such as unrhythmic heartbeat, hyperthyroidism, menopause, stress and other similar medical conditions. It affects ladies more during conditions like pregnancy, postpartum and menopause. It affects millions of people worldwide and due to changes in lifestyle and other chronic problems this number is increasing every year. This report studies the current and future aspects of insomnia market.

Download Free Sample: https://www.scalarmarketresearch.com/request-sample.php?id=1094

The report on the global Insomnia market uses the top-down and bottom-up approaches to define, analyze, and describe the market trends for the next five years. The report also tracks the emerging applications, innovative technologies, and mergers & acquisitions. It also focuses on the growth drivers and restraints for the key market players during the forecast period.

Enquiry Before Buying: https://www.scalarmarketresearch.com/enquire-before-buy.php?id=1094

KEY PREMIUM INDUSTRY INSIGHTS

1. The insomnia market is bound to increase worldwide because of changes in lifestyle, increase in stress at workplace, changes in work shifts, rise in the number of people suffering from insomnia, and rise in chronic diseases. The advancement in technology is another market driving factor that is helping to explore the untapped markets creating growth opportunities for the insomnia market.

2. In addition, the rise in demand for insomnia treatment options is boosting the market growth. Pharmaceutical companies are collaborating to find out newer treatment options and contributing towards the progress of the market.

3. However, the side effect of drugs for insomnia is hampering the growth of the market worldwide. Moreover, the process of patent creation and the regulations are also acting as a major market restraint.

The insomnia market is divided into four major geographical segments which are North America, Europe, Asia-Pacific, and Rest of the world. The North America region holds the highest market share and is the largest revenue contributor of the insomnia market. The region continues to dominate the global market due to emergence of new technologies and new treatments for insomnia. Next in line is the Europe region which is witnessing steady growth in the insomnia market during the forecasted period because of increase in stress. Asia-Pacific region has the least market share worldwide.

MARKET SEGMENTATION

This report analyzes the insomnia market by the following segments:

Insomnia Market, by Types of Therapy

1. Pharmacological Therapy
2. Non Pharmacological Therapy

Insomnia Market, by Drug Formulation

1. Capsules
2. Tablet
3. Others

Insomnia Market, by Diseases Condition

1. Poor Quality of Sleep
2. Sleep Maintenance

KEY MARKET PLAYERS

Key players in the insomnia market include:

1. Eisai, co.
2. Merck & co inc
3. Sanofi
4. Takeda Pharmaceutical Company
5. Pfizer, Inc.

Browse Report: https://www.scalarmarketresearch.com/market-reports/insomnia-market

About Scalar Market Research
Scalar Market Research, Inc., a U.S.-based market research and consulting firm, aspires to assist organizations from around the world to achieve their business goal with premium market research reports and consulting services. Our real-time industry tracking with the help of advanced analytics offers a crystal clear view of all the activities in niche markets. Our team, with thorough global understanding, works relentlessly to gather the necessary market insights, including customer analysis, competitions and global forecast.

Find out more about our services at: www.scalarmarketresearch.com